Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

CinCor Pharma, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19
   10-K10-KS-1/A
Revenues  0.00.03.9
            Revenue growth   -100.0% 
Cost of goods sold  0.00.05.1
Gross profit  0.00.0-1.2
            Gross margin    -30.8%
Selling, general and administrative   [+]42.521.11.2
Other operating expenses  -7.9-1.2-7.6
EBIT   [+]-34.6-19.95.1
            EBIT margin    130.8%
Interest income  0.00.00.1
Other income (expense), net  -15.8-2.4-0.2
Pre-tax income  -50.4-22.35.0
Income taxes  0.00.00.0
            Tax rate  0.0%0.0%0.0%
Net income  -50.4-22.35.0
            Net margin    128.2%
   
Basic EPS   [+]($32.52)($17.84)$4.03
Diluted EPS   [+]($32.52)($17.84)$4.03
   
Shares outstanding (basic)   [+]1.51.31.3
Shares outstanding (diluted)   [+]1.51.31.3
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy